Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cns Pharmaceuticals Inc (NQ: CNSP )

0.2150 +0.0110 (+5.39%)
Streaming Delayed Price Updated: 3:58 PM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 109,097
Open 0.2100
Bid (Size) 0.2110 (5)
Ask (Size) 0.2300 (24)
Prev. Close 0.2040
Today's Range 0.2000 - 0.2200
52wk Range 0.1900 - 2.750
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Researchers Seek to Develop Genetically Engineered Brain Cancer Treatment
Via Investor Brand Network
TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at LSX World Congress 2024
Via Investor Brand Network

Performance

YTD
-81.93%
-81.93%
1 Month
-41.89%
-41.89%
3 Month
-48.77%
-48.77%
6 Month
-88.62%
-88.62%
1 Year
-87.50%
-87.50%

More News

Read More
CNS Pharmaceuticals to Present at the LSX World Congress 2024
Via ACCESSWIRE
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Spotlighted in Upcoming Virtual Investor Lunch Break Event
Via Investor Brand Network
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity
Via ACCESSWIRE
New Research Sheds Light on the Initial Stages of Brain Cancer Development
Via Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Represents Opportunity to Provide Solution for GBM Patients
Via Investor Brand Network
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Researchers Link Hormone Treatments to Heightened Risk of Brain Tumors
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases FY 2023 Financial Report, Corporate Update
Via Investor Brand Network
CNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q4 2023
Via InvestorPlace
CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements
Via ACCESSWIRE
CNS Pharmaceuticals to Present at Two Investor Conferences in April
Via ACCESSWIRE
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Welcomes Proven Commercialization Leader to Its Board of Directors
Via Investor Brand Network
Study Shows Troops That Sustain Serious Brain Injuries Have Higher Risk of Brain Cancer
Via Investor Brand Network
Top 5 Health Care Stocks That Are Preparing To Pump In February
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Scientists Start Trialing First Blood Test Against Brain Cancer
Via Investor Brand Network
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases Information on $4M Public Offering Pricing
Via Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.